Atlanta Braves outfielder Jurickson Profar will miss the entire 2026 MLB season after his appeal for a 162-game suspension was denied following a second positive test for performance-enhancing drugs, a catastrophic loss that strips the team of its All-Star designated hitter and $15 million in salary.
The Atlanta Braves’ 2026 World Series aspirations have taken a devastating hit before Opening Day. Jurickson Profar, the team’s All-Star outfielder and projected cleanup hitter, will not play a single game this year after his appeal of a 162-game suspension was resolved, according to Associated Press sources. The discipline stems from a positive test for exogenous testosterone, meaning testosterone not naturally produced by his body, marking his second violation of Major League Baseball’s drug policy.
A Pattern of Missteps: From hCG to Exogenous Testosterone
This suspension is not Profar’s first rodeo with MLB’s drug program. On March 31, 2025, he served an 80-game ban after testing positive for Chorionic Gonadotrophin (hCG), a hormone that stimulates testosterone production [Associated Press]. At the time, Profar issued a statement accepting responsibility but claiming he never willingly took a banned substance. The current violation, involving exogenous testosterone, is considered more severe under the joint drug prevention and treatment program, leading to the maximum penalty for a second offense: a full-season ban.
Financial Carnage: $15 Million Vanishes from Profar’s Ledger
The financial repercussions are immediate and severe. Profar is due $15 million in salary for the 2026 season, which he will now forfeit entirely under the terms of his contract. This comes on the heels of losing half his $12 million salary in 2025 due to the initial suspension [Associated Press]. His $42 million, three-year deal, signed to keep him in Atlanta through 2027, now looks like a massive miscalculation for both player and team, with over $27 million potentially lost to suspensions.
Braves’ Pre-Planned Adjustments and Weiss’s Stoic Outlook
First-year manager Walt Weiss has known about Profar’s situation for almost a month, giving the coaching staff time to recalibrate. Weiss has invoked the Braves’ 2021 World Series triumph, which occurred despite losing Ronald Acuña Jr. to a torn ACL, as a blueprint for resilience. “The moral of the story is something good is likely to come from the bad news,” Weiss told reporters on March 4 [Associated Press]. The club itself released a statement expressing “incredible disappointment” and full support for MLB’s drug program, emphasizing that players are consistently educated on its rules.
Profar’s Peak Performance and the Surgery Timeline
Before these setbacks, Profar was emerging as one of baseball’s most potent hitters. In 2024, he earned his first All-Star selection after posting career-best numbers: a .280 batting average, 24 home runs, 85 RBIs, and an .839 OPS. Last season, after returning from his first suspension, he hit .245 with 14 homers and 43 RBIs in 80 games, including a homer on July 2 [Associated Press]. Profar also revealed he underwent sports hernia surgery in November 2025, requiring a six-week recovery, and he went 3-for-10 with three RBIs in four spring training games this year.
Fan Frenzy: Rumors, Replacements, and What-If Scenarios
The Braves’ fanbase is now inundated with speculation. Without Profar slated as the primary designated hitter and likely No. 2 batter behind Acuña, expect intense debate over internal solutions. Veteran Adam Duvall could see increased DH duties, while Marcell Ozana might shift from first base to the outfield to open a spot. The trade rumor mill will inevitably heat up for a bat like Jesús Sánchez or Joc Pederson. Social media is already dissecting the parallels to 2021, when the Braves overcame Acuña’s loss to win it all—a narrative that offers hope but ignores the different context of a self-inflicted, season-long void.
The Bigger Picture: MLB’s PED Policy Under Microscope
Profar’s case highlights MLB’s tough stance on repeat offenders. The league’s drug program mandates a minimum 80-game ban for a first violation and a full season for a second, with no appeal after announcement for subsequent positives. Unlike the initial suspension, where appeals typically delay discipline, the rules for a second offense are clear and non-negotiable. This incident will fuel discussions about player education and the pressures that might lead to poor decisions, but the league’s message remains unambiguous: repeat violations come with severe consequences.
For the fastest, most authoritative analysis of breaking sports stories and deep-dive features like this, only onlytrustedinfo.com delivers the insights that separate winners from the pack. Stay tuned for continuous coverage as the Braves navigate this unprecedented challenge.
